ASTRAZENECA PENSIONS TRUSTEE LIMITED

1. Financial Health Score: A (Healthy/Normal for Classification)

Explanation: This company scores an 'A' not because it is generating massive revenues, but because it is in perfect health for its specific "species" of company. ASTRAZENECA PENSIONS TRUSTEE LIMITED is classified as a Dormant company. Like a patient in a medically induced coma or a hibernating bear, a flatlined operational heartbeat is the expected, healthy state. The company is active, fully compliant, and fulfilling its structural purpose without any symptoms of financial distress.

2. Key Vital Signs

• Pulse (Trading Activity): Flatlined by design. As a dormant company, it has no significant financial transactions. For a standard trading company, this would be a critical symptom of terminal decline; for a pensions trustee entity, this is the expected resting heart rate.
• Blood Pressure (Financial Liabilities): Stable and minimal. The company has no reported current or long-term liabilities weighing down its system. Its only financial anatomy is a share capital of £250,000, which acts as a healthy baseline of corporate "blood volume" ensuring the entity has a formal financial foundation.
• Compliance Immune System: Robust. The company’s filing vitals are strong. Accounts are up to date (last made up to 31 Dec 2025) and the confirmation statement is current (last made up to 16 Sep 2025), with no overdue filings. This shows a strong immune system against Companies House penalties.
• Corporate DNA (Governance & Control): Well-structured. The ownership and control vitals are healthy. The Law Debenture Trust Corporation Plc acts as a corporate director and Person with Significant Control (PSC), providing professional, independent institutional oversight—a highly robust genetic makeup for a pension trustee board.

3. Diagnosis

Diagnosis: Healthy Suspended Animation

The financial data reveals a business that is functioning exactly as intended. This entity was established to act solely as a trustee for the AstraZeneca pension scheme, not to trade or generate profit. Therefore, its dormant status is not a symptom of illness, but rather a sign that the corporate body is resting peacefully while its parent organization (AstraZeneca) manages the actual pension scheme assets elsewhere.

Symptoms Analysis: * No Revenue/Profit: A non-issue here. The "nutrients" (funds) for the pension scheme flow through the main AstraZeneca corporate body, not this trustee shell. * Director Turnover: Recent changes in the board—such as the resignation of Graham Peter Colbert and appointment of new directors like Rebekah Martin and Kevin Jones—are akin to routine cell turnover. They show active, ongoing governance rather than internal organ failure. * Historical Scarring: The previous name change from ZENECA PENSIONS TRUSTEE LIMITED in 2001 is simply an old, fully healed scar from the historical Zeneca/Astra merger, showing normal corporate evolution.

4. Recommendations

Even though the patient is in perfect health for its dormant state, routine preventative care is required to maintain wellness:

1. Maintain the Governance Immune System: Continue to prioritize punctual filing of dormant accounts and confirmation statements. A dormant company is highly susceptible to administrative "infections" (fines and penalties) if compliance slips.
2. Monitor Board Vital Signs: Ensure that as directors resign (as seen recently), they are swiftly replaced. A pensions trustee requires a fully functioning board "brain" to make fiduciary decisions, even if the corporate body is financially dormant.
3. Prevent Accidental Wake-Up: Guard against any unintended financial transactions that could "wake up" the company from its dormant state. Even small, unauthorized financial movements could change the filing requirements and complicate the company's clean, simple structure.